Asset
Urcosimod
OKYO Pharma Limited Ordinary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05759208 | phase2 | completed | 2023-04-28 | 2023-12-15 | Okyo Pharma Ltd | The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease |
FDA applications (0)
This company has no applications containing this asset.